Hints and tips:
...Kimberly Smith, head of research and development at ViiV, said a long-acting drug administered every 12 months would soon be attainable: “I can’t say when, but not too far beyond the end of this decade....
...John Kimberly is professor of entrepreneurial studies at the Wharton School, University of Pennsylvania, in the US....
International Edition